Furthermore, these synthesized compounds can inhibit epidermal growth factor receptor (EGFR) (IC50: 0.24 μM), proto-oncogene tyrosine-protein kinase (Src) (IC50: 0.96 μM), and interleukin-6 (IL-6) (% of control: 20%) and might play anticancer roles in various cancers [73]. The gene discussed is EGFR; the disease is cancer.